Company tied to Trump Jr. to host summit for top drugmakers, WSJ reports

BlinkRx, an online prescription drug delivery company with Donald Trump Jr. on its board, is hosting a summit for top drugmakers, The Wall Street Journal’s Annie Linksey and Josh Dawsey report. The summit, co-hosted by 1789 Capital, which led a $140M funding round for BlinkRx, is expected to include senior Trump administration officials, according to the report, which adds that BlinkRx stands to benefit from a shake-up of how patients buy drugs after President Trump urged pharmaceutical companies to sell their medicines directly to consumers. Other publicly traded companies in the space include GoodRx (GDRX).